Stocks / NASDAQ / Clearside Biomedical, Inc.

Clearside Biomedical, Inc.

Our Opinion

Clearside Biomedical, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The following report cites that the company uses animals for product testing.

“Clearside shall have the responsibility for contracting, under a separate agreement, with a contract research organization (“CRO”) selected by Clearside and reasonably acceptable to SANTEN to conduct injectability testing, drug property improvement, animal housing, animal injection, and animal monitoring and testing under non-GLP conditions, all in accordance with the applicable Feasibility Study unless otherwise agreed by the Parties.” (Page 2) Read the full document.

Company Description

Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which develops drug therapies to treat chronic, blinding diseases of the eye, with a particular emphasis on diseases affecting the choroid and retina. The company was founded by Samirkumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry Edelhauser in May 2011 and is headquartered in Alpharetta, GA. [Submit: MarketWatch]

Company Website: